Results 31 to 40 of about 3,798 (162)

Continuous terlipressin infusion is associated with improved diet intake and muscle strength in patients awaiting liver transplant

open access: yesJHEP Reports, 2019
Background & Aims: Portal hypertension contributes to the pathogenesis of malnutrition and sarcopenia in cirrhosis via multiple mechanisms. Terlipressin is a vasopressin analogue that we administer via continuous outpatient infusion, as a bridge to ...
Brooke Chapman   +8 more
doaj   +1 more source

Effects of terlipressin infusion during hepatobiliary surgery on systemic and splanchnic haemodynamics, renal function and blood loss: a double-blind, randomized clinical trial

open access: yesBMC Anesthesiology, 2019
Background Terlipressin, in general, is a vasopressor which acts via V1 receptors. Its infusion elevates mean blood pressure and can reduce bleeding which has a splanchnic origin.
Magdy Mohammed Mahdy   +12 more
doaj   +1 more source

Elevated liver regeneration in response to pharmacological reduction of elevated portal venous pressure by terlipressin after partial hepatectomy. [PDF]

open access: yes, 2014
BACKGROUND Liver regeneration is of crucial importance for patients undergoing living liver transplantations or extended liver resections and can be associated with elevated portal venous pressure, impaired hepatic regeneration, and postoperative ...
Candinas, Daniel   +7 more
core   +2 more sources

Severe Bradycardia Associated with the Use of Terlipressin: A Case Report

open access: yesCase Reports in Gastroenterology
Introduction: Although terlipressin is known to cause bradycardia, this adverse effect is usually described in association with hypertension and is considered a benign compensatory response mediated by arterial baroreceptors.
Alex Yartsev, Jessica T. Nguyen
doaj   +1 more source

Role of RIPK1/RIPK3/MLKL signalling pathway in sepsis‐associated acute kidney injury

open access: yesExperimental Physiology, EarlyView.
Abstract Sepsis‐associated acute kidney injury (SA‐AKI) is a common clinical syndrome in critically ill patients, and its high mortality rate is closely related to complex pathological mechanisms. Existing studies have shown that the pathophysiological process of SA‐AKI involves complex multi‐mechanism interactions, including an uncontrolled systemic ...
Huijun Yin, Jingyi Wang, Huirong Han
wiley   +1 more source

Worsening of cerebral hyperemia by the administration of terlipressin in acute liver failure with severe hepatic encephalopathy [PDF]

open access: yes, 2004
There is increasing evidence that terlipressin is useful in patients with cirrhosis and hepatorenal syndrome, but there are no data of its use in patients with acute liver failure (ALF) in whom hepatorenal syndrome is common.
Jalan, R.   +6 more
core  

Influence of Albumin Treatment Duration on Outcome of Terlipressin Therapy in Patients With HRS‐AKI

open access: yesLiver International, Volume 46, Issue 11, November 2026.
ABSTRACT Background and Aims Volume expansion with albumin is recommended to establish a diagnosis of hepatorenal syndrome–acute kidney injury (HRS‐AKI). The optimal duration of albumin administration is debated and requires balancing the risk of overtreatment with the need for timely diagnosis and treatment.
Eva Maria Schleicher   +33 more
wiley   +1 more source

Terlipressin-Related Acute Myocardial Infarction: A Case Report and Literature Review

open access: yesKaohsiung Journal of Medical Sciences, 2004
Acute ST-segment elevation myocardial infarction after the administration of terlipressin in patients with hemorrhagic esophageal varices is a rare but life-threatening complication.
Min-Yi Lee   +7 more
doaj   +1 more source

Terlipressin combined with conservative fluid management attenuates hemorrhagic shock-induced acute kidney injury in rats

open access: yesScientific Reports, 2022
Hemorrhagic shock (HS), a major cause of trauma-related mortality, is mainly treated by crystalloid fluid administration, typically with lactated Ringer’s (LR).
Leticia Urbano Cardoso Castro   +10 more
doaj   +1 more source

Terlipressin as an adjunct vasopressor in refractory hypotension after tricyclic antidepressant intoxication

open access: yes, 2006
AIM OF STUDY: To report the management of cardiovascular failure refractory to standard catecholamine therapy with terlipressin in a patient with tricyclic antidepressant (TCA) intoxication. CASE REPORT: A 41-year-old woman, with suicidal ingestion of 11.
Dünser, Martin W   +4 more
core   +1 more source

Home - About - Disclaimer - Privacy